Project: Gyroplexed Nucleosomic® biomarker panels for lung cancer screening
| Acronym | GyroNuQ (Reference Number: 113485) |
| Duration | 01/10/2019 - 03/04/2022 |
| Project Topic | We propose the development of a triaging test for Low Dose Computed Tomography positive individuals using simple, low cost Nu.Q™ immunoassay profiling of circulating, cell free nucleosomes on a multi-parallel, high throughput platform - Gyroplex™. Deliverables include: 12 Gyro-Nu.Q™ Research Use assays in high sensitivity Gyroplex™ format; Nu.Q™ profiles to differentiate lung cancer from benign disease; Validated Triage panel in a prospectively collected cohort ready for regulatory trials. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 11 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Belgian Volition SPRL | Coordinator | Belgium |
| 2 | Gyros Protein Technologies AB | Partner | Sweden |